3+ day, 15+ hour ago   (410+ words) Biological age testing is having a moment, and it has just gained a foothold in one of the world’s most aging-literate markets. GlycanAge, the UK-based company behind a glycan test that measures inflammaging, has signed a memorandum of understanding with…...

3+ day, 16+ hour ago   (846+ words) Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life. With a keen interest in all things geroscience,…...

3+ day, 15+ hour ago   (589+ words) It starts small. A flutter in the chest on the stairs. A dizzy spell that passes before you’ve even sat down. Most people shrug it off, or mention it to a doctor who sends them home with a monitor strapped…...

4+ day, 14+ hour ago   (351+ words) The tool doctors have relied on for years to track ALS was built to measure grip strength and swallowing, not memory or mood. That gap is what Cumulus Neuroscience is trying to close, and its first real test of whether…...

4+ day, 14+ hour ago   (303+ words) There’s a line that Neko Health likes to point to: 25,000 New Yorkers signed up before the company had even picked a paint color for its walls. It’s a waitlist number for a clinic that hadn’t opened yet, in a city…...

5+ day, 15+ hour ago   (365+ words) Part of a ten-part series profiling each of the $101 million XPRIZE Healthspan competition’s Milestone 2 Awardees. Across the series, Longevity.Technology examines the science behind each team’s approach, the trial data supporting it and what stands between them and the competition’s…...

5+ day, 15+ hour ago   (522+ words) Longevity.Technology New ALS drug data reveal a mitochondrial fix Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: NRG Therapeutics unpacks…...

6+ day, 15+ hour ago   (191+ words) Long before a patient ever shows a tremor, Parkinson’s disease may already be rewriting the biology of their brain. That gap, between when the disease actually starts and when doctors can currently detect it, is one of the biggest obstacles…...

1+ week, 5+ day ago   (250+ words) The underlying science traces back more than 25 years to work by Professor Michal Schwartz, ImmunoBrain’s scientific co-founder, whose research challenged the long-held assumption that the brain operates in isolation from the body’s immune defenses. As with the tau-targeting therapies emerging…...

1+ week, 6+ day ago   (480+ words) Greenstone Biosciences, a Palo Alto biotech built around a biobank of more than 2,500 donor-derived induced pluripotent stem cell (iPSC) lines, has just received fresh federal backing to test whether skipping the animal step altogether can produce better drugs, faster [1]. The…...